Related Experiment Video
Updated: Jul 20, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
KLF4 suppresses transformation of pre-B cells by ABL oncogenes
Michael G Kharas1, Isharat Yusuf, Vanessa M Scarfone
1Department of Molecular Biology and Biochemistry, University of California-Irvine, 3242 McGaugh Hall, Irvine, CA 92697-3900, USA.
Abstract:
Genes that are strongly repressed after B-cell activation are candidates for being inactivated, mutated, or repressed in B-cell malignancies. Krüppel-like factor 4 (Klf4), a gene down-regulated in activated murine B cells, is expressed at low levels in several types of human B-cell lineage lymphomas and leukemias. The human KLF4 gene has been identified as a tumor suppressor gene in colon and gastric cancer; in concordance with this, overexpression of KLF4 can suppress proliferation in several epithelial cell types. Here we investigate the effects of KLF4 on pro/pre-B-cell transformation by v-Abl and BCR-ABL, oncogenes that cause leukemia in mice and humans. We show that overexpression of KLF4 induces arrest and apoptosis in the G1 phase of the cell cycle. KLF4-mediated death, but not cell-cycle arrest, can be rescued by Bcl-XL overexpression. Transformed pro/pre-B cells expressing KLF4 display increased expression of p21CIP and decreased expression of c-Myc and cyclin D2. Tetracycline-inducible expression of KLF4 in B-cell progenitors of transgenic mice blocks transformation by BCR-ABL and depletes leukemic pre-B cells in vivo. Collectively, our work identifies KLF4 as a putative tumor suppressor in B-cell malignancies.
Insights
Krüppel-like factor 4 (KLF4) suppresses B-cell leukemia by inducing cell cycle arrest and apoptosis. KLF4 acts as a tumor suppressor, blocking oncogene-driven transformation and depleting leukemic cells in vivo.
Area of Science:
- Molecular Biology
- Cancer Biology
- Hematology
Background:
- Genes repressed during B-cell activation are implicated in B-cell malignancies.
- Krüppel-like factor 4 (KLF4) is downregulated in activated B cells and expressed at low levels in B-cell lymphomas and leukemias.
- KLF4 functions as a tumor suppressor in epithelial cancers, inhibiting proliferation.
Purpose of the Study:
- To investigate the role of KLF4 in pro/pre-B-cell transformation induced by v-Abl and BCR-ABL oncogenes.
- To determine the effects of KLF4 on cell cycle progression, apoptosis, and oncogene-driven leukemogenesis.
Main Methods:
- Overexpression of KLF4 in pro/pre-B cells and analysis of cell cycle phase and apoptosis.
- Assessment of KLF4's impact on key cell cycle regulators (p21CIP, c-Myc, cyclin D2).
- Utilizing tetracycline-inducible KLF4 expression in transgenic mouse models with BCR-ABL-induced leukemia.
Main Results:
- KLF4 overexpression induces G1 cell cycle arrest and apoptosis in transformed pro/pre-B cells.
- KLF4-induced apoptosis is partially rescued by Bcl-XL, while cell cycle arrest is not.
- KLF4 upregulates p21CIP and downregulates c-Myc and cyclin D2, inhibiting transformation and depleting leukemic cells in vivo.
Conclusions:
- KLF4 functions as a tumor suppressor in B-cell malignancies.
- KLF4 inhibits BCR-ABL-driven leukemogenesis by inducing cell cycle arrest and apoptosis.
- KLF4 represents a potential therapeutic target for B-cell leukemias and lymphomas.
Related Concept Videos
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

